¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦ 51Â÷ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãß°è±¹Á¦Çмú´ëȸ : 2019-11-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦ 51Â÷ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãß°è±¹Á¦Çмú´ëȸ : 2019-11-09
±³À°ÀÏÀÚ : 2019-11-09
±³À°Àå¼Ò : ¼­¿ï, ÄÜ·¡µåÈ£ÅÚ(¿©Àǵµ) ±×·£µåº¼·ë  
±³À°ÁÖÁ¦ : Á¦ 51Â÷ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãß°è±¹Á¦Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ°íÇ÷¾ÐÇÐȸ
´ã´çÀÚ : Á¤º°
¿¬¶ôó : 02-565-3350  
À̸ÞÀÏ : ksh@koreanhypertension.org      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ¿Ü°ú, ½Å°æ°ú, °¡Á¤ÀÇÇаú¿¹¹æÀÇÇÐ, »ý¸®ÇÐ, ÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 600¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í *»çÀüµî·Ï: Á¤È¸¿ø(6¸¸¿ø),Á¤È¸¿ø ¿Ü(8¸¸¿ø), Àü°øÀǹױâŸ(4¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç(2¸¸¿ø), Çлý-´ëÇÑ¿ø»ý Á¦¿Ü/º¸°Ç´ë/°£È£´ë/ÀÇ´ë(¹«·á)/65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á) *ÇöÀåµî·Ï:ȸ¿ø(8¸¸¿ø),ºñȸ¿ø(10¸¸¿ø), Àü°øÀǹױâŸ(5¸¸¿ø), °£È£»ç/¿µ¾ç»ç/¾à»ç(2¸¸¿ø), Çлý-´ëÇÑ¿ø»ý Á¦¿Ü/º¸°Ç´ë/°£È£´ë/ÀÇ´ë(¹«·á)/65¼¼ ÀÌ»ó Á¤È¸¿ø(¹«·á)      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-09 Room D 07:00~07:15 Management of stage 1 hypertension by AHA guideline with risk factor clustering  Eugene Yang(USA,University of Washington School of Medicine) 
±³À°½Ã°£ 11-09 Room D 07:15~07:30 Case presentation: prehypertension or grade 1 hypertension with risk factor clustering  Á¤Çý¹®(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 07:30~07:45 Management of hypertension in very old patient  Kazuomi Kario(Japan, Jichi Medical University School of Medicine) 
±³À°½Ã°£ 11-09 Room D 07:45~08:00 Case presentation: very old hypertension patient  Çã¶õ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-09 Room A 09:00~09:15 What is new in the 2018 Chinese Hypertension Guidelines?  Jing Liu(China, Peking University People¡¯s Hospital) 
±³À°½Ã°£ 11-09 Room A 09:15~09:30 Hypertension Guidelines Debate: Japanese Perspective  Kazuomi Kario(Japan, Jichi Medical University School of Medicine) 
±³À°½Ã°£ 11-09 Room A 09:30~09:45 Controversies over Defining Hypertension and its Blood Pressure Targets: time for Arteries to step in  JK Cruickshank(UK, King¡¯s College London) 
±³À°½Ã°£ 11-09 Room A 09:45~10:00 Asian perspectives in hypertension and cardiovascular protection  Eugene Yang(USA,University of Washington School of Medicine) 
±³À°½Ã°£ 11-09 Room A 10:00~10:15 Philipine perspectives in hypertension guidelines  Nannette R. Rey(Philippine, De La Salle Medical and Health Sciences Institute) 
±³À°½Ã°£ 11-09 Room A 10:15~10:30 Panel Discussion  ½ÅÁøÈ£,±è±¤ÀÏ,ÀÓ»óÇö(ÇѾçÀÇ´ë,¼­¿ïÀÇ´ë,°¡Å縯ÀÇ´ë) 
È޽Ġ11-09 Park Ballroom 10:30~11:40 Moderated poster with coffee break  () 
±³À°½Ã°£ 11-09 Room D 10:30~10:45 Day to day variability of Home BP and CVD  ±è±¤ÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 10:45~11:00 Outcome researches of Home BP monitoring  È²ÈñÁ¤(°æÈñÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 11:00~11:15 Targeting nocturnal HTN using Home BP monitoring  ¹Ú»ó¹Î() 
±³À°½Ã°£ 11-09 Room D 11:15~11:30 Application of home BP in CKD  ÁöÁ¾Çö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-09  11:30~11:40 Panel Discussion  À§Áø,ÃÖÀçÇõ,ÀÌ»óÀº(°¡ÃµÀÇ´ë,ÇѸ²ÀÇ´ë,ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 11-09 Room A,B,C 11:40~12:20 Role of ambulatory blood pressure monitoring in hypertension management  Luis M. Ruilope(Spain, Autonoma University) 
±³À°½Ã°£ 11-09 Room A,B,C 12:20~12:50 Genomics and precision medicine of hypertension and related vascular traits  Norihiro Kato(Japan, National Center for Global Health and Medicine) 
±³À°½Ã°£ 11-09 Room D 12:50~13:05 Options in using non-mercury device  ¹Ú»ó¹Î(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 13:05~13:20 Clinical application of arterial function  JK Cruickshank(UK, King¡¯s College London) 
±³À°½Ã°£ 11-09 Room D 13:20~13:45 How to measure arterial stiffness  ¹®Á¤±Ù(°¡ÃµÀÇ´ë) 
È޽Ġ11-09  13:45~14:20 coffee break  () 
±³À°½Ã°£ 11-09 Room A 14:20~14:35 °íÇ÷¾ÐÀÇ ¿øÀÎÀº ¹«¾ùÀÌ¸ç ¿Ö Áß¿äÇÑ°¡ ?  ¹Ú¼ºÇÏ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-09 Room A 14:35~14:50 °íÇ÷¾Ð ½ÅȯÀ» Áø·áÇÒ ¶§ ¹Ýµå½Ã Æò°¡ÇؾßÇÏ´Â °ÍÀº ?  ±è´ëÈñ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-09 Room A 14:50~15:05 out of office BP vs. office BP measurement  ÀÓ»óÇö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-09 Room A 15:05~15:20 °íÇ÷¾ÐÀÇ Ä¡·á¸¦ ¾îµð±îÁö ÇؾßÇϴ°¡? Ä¡·á°¡ ÀßµÇ¸é ¾àÁ¦¸¦ ²÷À» ¼ö Àִ°¡?  Á¶ÀºÁÖ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-09 Room A 15:20~15:30 Panel Discussion  ÀÌÀº¹Ì,±è±¤ÀÏ,¹Ú¿ëÇö(¿ø±¤ÀÇ´ë,¼­¿ïÀÇ´ë,ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 15:30~15:45 Epidemiologic perspectives of hypertension in heart failure  ÇѼº¿ì(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 15:45~16:00 Intensive BP control, should it be considered for prevention of HF?  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 16:00~16:15 Anyone or someone, is there any difference in antihypertensive agents?  ±è¿ëÇö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 16:15~16:30 SGLT2 inhibitor, can it prevent HF in hypertensive patients with diabetes?  ±è¼ºÇØ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-09 Room D 16:30~16:45 Panel Discussion  ÀÌ»óÀç,ÃÖ¼®¿ø,¼ÕÁ¤¿ì(¿ø±¤ÀÇ´ë,ÇѸ²ÀÇ´ë,¿¬¼¼¿øÁÖÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦ 51Â÷ ´ëÇÑ°íÇ÷¾ÐÇÐȸ Ãß°è±¹Á¦Çмú´ëȸ : 2019-11-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæ°úÀÇ»çȸ Á¦12Â÷ Ä¡¸ÅƯº°µî±Þ ÀÇ»ç¼Ò°ß¼­ ÀÛ¼º±³À° : 2019-11-10
´ÙÀ½±Û 2019 ´ëÇÑÀÇ·áÁ¤º¸ÇÐȸ Ãß°èÇмú´ëȸ(2ÀÏÂ÷) : 2019-11-09
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 87 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 50 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 57 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 62 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 54 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 55 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 28 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 22 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 48 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 25 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 23 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 58 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 41 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 45 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 35 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷